International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions

TJ BOS; SL COHN; HK KLEINMAN; J KOBLINSKI; JE MURPHY-ULLRICH; OL PODHAJCER; SA REMPEL; JN RICH; JT RUTKA; EH SAGE; EW THOMPSON

MATRIX BIOLOGY

ELSEVIER SCIENCE BV

Año: 2004 vol. 23 p. 63 - 69

0945-053X

The second of the Hermelin Brain Tumor Center Symposia was held once again at Henry Ford Hospital in Detroit, Michigan on October 24th and 25th, 2003. A public conference was held on the 24th while a closeddoor session took place on the 25th. The purpose of these symposia is to bring together experts in a particular field of study with the aim to share information with each other and the public, but then to meet privately to present novel data, hold discussions, and share concepts. While the interaction is intended to benefit all involved, the incentive is the expectation that the shared information will aid researchers at the Hermelin Brain Tumor Center in their quest to identify potential therapeutic targets and explore translational therapeutic strategies for the treatment of patients suffering nervous system tumors.